DTx Pharma is based in San Diego. It has raised $114M in total funding. Latest round: Series B.
DTx Pharma funding overview
DTx Pharma is based in San Diego. DTx Pharma has raised $114M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for DTx Pharma runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Access Biotechnology, Surveyor Capital, Cormorant Asset Management, Janus Henderson Investors, Logos Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
DTx Pharma at a glance
Total raised
$114M
Latest round
Series B
Latest round date
February 2021
Headquarters
San Diego
Notable investors
RA Capital Management, Access Biotechnology, Surveyor Capital, Cormorant Asset Management, Janus Henderson Investors, Logos Capital, Friedman Bioventure Fund, Eli Lilly and Company
Frequently asked about DTx Pharma funding
How much has DTx Pharma raised?
DTx Pharma has raised $114M in total disclosed funding across the rounds on record.
Who has invested in DTx Pharma?
RA Capital Management, Access Biotechnology, Surveyor Capital, Cormorant Asset Management, Janus Henderson Investors, Logos Capital are named among the investors backing DTx Pharma.
What was the latest DTx Pharma funding round?
The most recent disclosed round is a Series B, announced in February 2021.
Where is DTx Pharma based?
DTx Pharma is based in San Diego.
When did DTx Pharma last raise?
The last disclosed DTx Pharma round closed in February 2021 at Series B.
Every DTx Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
